5.00
Schlusskurs vom Vortag:
$4.87
Offen:
$5
24-Stunden-Volumen:
2.09M
Relative Volume:
24.52
Marktkapitalisierung:
$255.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-103.21M
KGV:
-1.0869
EPS:
-4.6001
Netto-Cashflow:
$-26.70M
1W Leistung:
+5.26%
1M Leistung:
+30.89%
6M Leistung:
-13.64%
1J Leistung:
-24.36%
Engene Holdings Inc Stock (ENGN) Company Profile
Firmenname
Engene Holdings Inc
Sektor
Branche
Telefon
(514) 332-4888
Adresse
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Vergleichen Sie ENGN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ENGN
Engene Holdings Inc
|
5.00 | 245.30M | 0 | -103.21M | -26.70M | -4.6001 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-02-18 | Eingeleitet | Piper Sandler | Overweight |
2025-02-14 | Herabstufung | UBS | Buy → Neutral |
2024-12-23 | Eingeleitet | H.C. Wainwright | Buy |
2024-11-27 | Eingeleitet | Raymond James | Outperform |
2024-11-18 | Eingeleitet | JMP Securities | Mkt Outperform |
2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
2024-04-22 | Eingeleitet | Wells Fargo | Overweight |
2024-04-15 | Eingeleitet | Guggenheim | Buy |
2024-03-28 | Eingeleitet | UBS | Buy |
2024-03-08 | Eingeleitet | Morgan Stanley | Overweight |
2024-02-20 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten
Tick level data insight on enGene Holdings Inc. volatilityJuly 2025 Selloffs & Real-Time Volume Analysis - Newser
Detecting support and resistance levels for enGene Holdings Inc. Equity WarrantMarket Activity Report & Real-Time Chart Breakout Alerts - Newser
enGene Achieves Target Enrollment Milestone for LEGEND Trial Pivotal Cohort - PharmiWeb.com
How to read the order book for enGene Holdings Inc.July 2025 Spike Watch & Stepwise Trade Signal Implementation - Newser
Published on: 2025-09-03 08:51:17 - Newser
enGene Reaches Key Enrollment Milestone in LEGEND Trial for Bladder Cancer Therapy - TipRanks
Earnings visualization tools for enGene Holdings Inc. Equity WarrantChart Signals & Proven Capital Preservation Tips - Newser
enGene completes target enrollment for pivotal bladder cancer trial - Investing.com
Chart based analysis of enGene Holdings Inc. Equity Warrant trendsGap Down & Weekly High Potential Alerts - Newser
Published on: 2025-09-03 06:49:08 - Newser
How to forecast enGene Holdings Inc. Equity Warrant trends using time seriesMarket Movement Recap & Consistent Profit Trade Alerts - Newser
Can swing trading help recover from enGene Holdings Inc. Equity Warrant losses - Newser
Does enGene Holdings Inc. Equity Warrant have strong EBITDA marginsJuly 2025 Update & Capital Efficiency Focused Ideas - khodrobank.com
Should you wait for a breakout in enGene Holdings Inc.Weekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
How to build a custom watchlist for enGene Holdings Inc. Equity WarrantDollar Strength & Consistent Return Investment Signals - Newser
Is enGene Holdings Inc. Equity Warrant forming a double bottomJuly 2025 WrapUp & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Published on: 2025-09-03 04:27:58 - Newser
Visual analytics tools that track enGene Holdings Inc. performanceLong Setup & Consistent Income Trade Ideas - Newser
What machine learning models say about enGene Holdings Inc.Earnings Miss & Real-Time Volume Triggers - Newser
Leading vs lagging indicators on enGene Holdings Inc. Equity Warrant performance2025 Trading Volume Trends & Daily Profit Maximizing Tips - Newser
Can volume confirm reversal in enGene Holdings Inc.2025 Biggest Moves & Free Reliable Trade Execution Plans - Newser
enGene Holdings Inc. stock chart pattern explainedTrend Reversal & Reliable Volume Spike Alerts - Newser
Combining machine learning predictions for enGene Holdings Inc.Trade Entry Summary & Weekly Watchlist of Top Performers - Newser
Analyzing net buyer seller activity in enGene Holdings Inc.Trade Exit Summary & Reliable Price Breakout Alerts - Newser
Is enGene Holdings Inc. showing signs of accumulationJuly 2025 Big Picture & Step-by-Step Swing Trade Plans - Newser
Is enGene Holdings Inc. Equity Warrant stock ready for a breakoutJuly 2025 Opening Moves & Low Risk Investment Opportunities - Newser
Building trade automation scripts for enGene Holdings Inc.July 2025 Highlights & High Accuracy Investment Entry Signals - Newser
Custom watchlist performance reports with enGene Holdings Inc.2025 Technical Patterns & Free Community Consensus Stock Picks - Newser
enGene Holdings Inc. stock trendline breakdownStop Loss & Daily Stock Momentum Reports - Newser
Strategies to average down on enGene Holdings Inc. Equity Warrant2025 Market Sentiment & Community Driven Trade Alerts - Newser
Will enGene Holdings Inc. Equity Warrant benefit from government policyMarket Sentiment Summary & Growth Focused Investment Plans - khodrobank.com
Will enGene Holdings Inc. bounce back from current supportWeekly Profit Report & Technical Buy Zone Confirmations - Newser
Full technical analysis of enGene Holdings Inc. Equity Warrant stock - Newser
enGene Holdings Inc. Equity Warrant stock volume spike explainedJuly 2025 Trends & Safe Capital Growth Plans - Newser
How to recover losses in enGene Holdings Inc. Equity Warrant stock2025 Technical Overview & Stock Portfolio Risk Management - Newser
How to manage a losing position in enGene Holdings Inc.2025 Technical Overview & Low Volatility Stock Recommendations - Newser
Is enGene Holdings Inc. Equity Warrant a stock for growth or value investorsQuarterly Portfolio Report & Fast Gain Swing Alerts - khodrobank.com
Intraday pattern recognizer results for enGene Holdings Inc. Equity Warrant2025 Key Lessons & Capital Efficiency Focused Strategies - Newser
How to build a custom watchlist for enGene Holdings Inc.2025 Institutional Moves & Fast Momentum Stock Entry Tips - Newser
Can enGene Holdings Inc. Equity Warrant deliver consistent EPS growth2025 Risk Factors & Stock Portfolio Risk Management - khodrobank.com
Is enGene Holdings Inc. stock a good dividend stockIPO Watch & Risk Controlled Daily Trade Plans - khodrobank.com
Update Recap: What hedge funds are buying enGene Holdings Inc.Quarterly Profit Review & High Return Trade Opportunity Guides - khodrobank.com
Published on: 2025-09-02 00:11:07 - Newser
Can enGene Holdings Inc. Equity Warrant reach all time highs this yearJuly 2025 Volume & Long-Term Investment Growth Plans - khodrobank.com
Can enGene Holdings Inc. stock double in the next yearJuly 2025 Breakouts & Verified Momentum Watchlists - خودرو بانک
Is enGene Holdings Inc. forming bullish engulfing patternsAnalyst Downgrade & Reliable Trade Execution Plans - khodrobank.com
Is enGene Holdings Inc. a defensive stockNew Guidance & Technical Pattern Recognition Alerts - khodrobank.com
Bearish Setup: What’s next for enGene Holdings Inc. stockPortfolio Risk Summary & Stepwise Entry and Exit Trade Signals - khodrobank.com
Automated trading signals detected on enGene Holdings Inc.July 2025 Reactions & Momentum Based Trading Ideas - Newser
Is enGene Holdings Inc. benefiting from interest rate changesJuly 2025 Update & Growth Focused Entry Reports - khodrobank.com
Will enGene Holdings Inc. Equity Warrant stock hit new highs in YEARJuly 2025 Outlook & High Return Stock Watch Alerts - khodrobank.com
Finanzdaten der Engene Holdings Inc-Aktie (ENGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Engene Holdings Inc-Aktie (ENGN) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Forbion Growth Opportunities F | 10% Owner |
Sep 30 '24 |
Buy |
6.34 |
341,332 |
2,163,362 |
2,400,791 |
Forbion Growth Opportunities F | 10% Owner |
Sep 27 '24 |
Buy |
5.97 |
41,639 |
248,699 |
2,059,459 |
Forbion Growth Opportunities F | 10% Owner |
Oct 01 '24 |
Buy |
6.44 |
35,279 |
227,158 |
2,436,070 |
Forbion Growth Opportunities F | 10% Owner |
Oct 07 '24 |
Buy |
6.55 |
11,844 |
77,531 |
2,469,833 |
Forbion Growth Opportunities F | 10% Owner |
Oct 02 '24 |
Buy |
6.37 |
10,153 |
64,697 |
2,446,223 |
Forbion Growth Opportunities F | 10% Owner |
Oct 04 '24 |
Buy |
6.54 |
5,997 |
39,242 |
2,457,989 |
Forbion Growth Opportunities F | 10% Owner |
Oct 03 '24 |
Buy |
6.48 |
5,769 |
37,397 |
2,451,992 |
Forbion Growth Opportunities F | 10% Owner |
Oct 08 '24 |
Buy |
6.60 |
800 |
5,278 |
2,470,633 |
Cooper Ronald Harold Wilfred | Chief Executive Officer |
Sep 27 '24 |
Buy |
5.70 |
10,000 |
57,000 |
10,000 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):